Gems Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Delhi, Delhi, India, established in 1990.
1990 Delhi, Delhi, India Active
Last Updated:
Access Report
About Gems Drugs Private Limited

Gems Drugs Private Limited, a active private limited company, was established on 29 June 1990 in Delhi, Delhi, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24232DL1990PTC040668. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Ritu Nayyar (Director), Rajeev Nayyar (Director), Sahil Nayyar (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at F-183, G.F. Mangal Bazar, Laxmi Nagar,, Delhi, Delhi, 110092.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL1990PTC040668

  • Registration Number

    040668

  • Incorporation Date

    29 June 1990

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 35 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Gems Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gems Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gems Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Ritu Nayyar Director 01 Apr 2007 Current
Rajeev Nayyar Director 13 Jul 1990 Current
Sahil Nayyar Director 06 Oct 2006 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gems Drugs.

Gems Drugs Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Gems Drugs revenue growth over time
Gems Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gems Drugs?

In 2017, Gems Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gems Drugs?

Unlock and access historical data on people associated with Gems Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gems Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gems Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gems Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Gems Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Gems Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was completed.

  • Director Appointment

    Progress on Ritu Nayyar was appointed as a Director was appointed as a Director on 01 Apr 2007 & has been associated with this company since 18 years 11 months . was documented.

  • Director Appointment

    The activity Sahil Nayyar was appointed as a Director was appointed as a Director on 06 Oct 2006 & has been associated with this company since 19 years 4 months . was completed.

  • Director Appointment

    Rajeev Nayyar was appointed as a Director was appointed as a Director on 13 Jul 1990 & has been associated with this company since 35 years 7 months . was recorded as a recent event.

  • Company Incorporation

    The activity Gems Drugs Private Limited was registered on 29 Jun 1990 with Roc Delhi I & aged 35 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gems Drugs Private Limited?

The CIN of Gems Drugs Private Limited is U24232DL1990PTC040668.

Where is Gems Drugs Private Limited headquartered?

Gems Drugs Private Limited is headquartered at F-183, G.F. Mangal Bazar, Laxmi Nagar,, Delhi, Delhi, 110092.

When was Gems Drugs Private Limited incorporated?

Gems Drugs Private Limited was incorporated on 29 June 1990.

Who are the current directors of Gems Drugs Private Limited?

The current directors of Gems Drugs Private Limited are

What is the primary industry of Gems Drugs Private Limited?

The primary industry of Gems Drugs Private Limited is Manufacturing.

Is Gems Drugs Private Limited a listed company?

Gems Drugs Private Limited is unlisted.

What is the capital structure of Gems Drugs Private Limited?

The authorized capital of Gems Drugs Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Gems Drugs Private Limited?

The compliance status of Gems Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available